NCT01982812View on ClinicalTrials.gov

A Safety and Feasibility Study of Enteral LVT vs. Standard of Care for Seizure Control in Pediatric CM

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
SeizureEpilepsyCerebral Malaria
Interventions
DRUG

Oral Levetiracetam

liquid, 40 mg/kg loading dose and 30mg/kg every 12 hours via nasogastric tube for 3 days

DRUG

Standard AED

Active comparitor, Standard AED

Trial Locations (1)

3

Queen Elizabeth Central Hospital, Blantyre

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

University of Rochester

OTHER

NCT01982812 - A Safety and Feasibility Study of Enteral LVT vs. Standard of Care for Seizure Control in Pediatric CM | Biotech Hunter | Biotech Hunter